Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

FK506-induced intractable leukoencephalopathy following allogeneic bone marrow transplantation

Abstract

FK506-related leukoencephalopathy has been reported to be reversible and readily treated by discontinuation or reduction of FK506. We describe two pediatric cases of FK506-related leukoencephalopathy following allogeneic bone marrow transplantation, which could not be readily controlled. These cases show that FK506-related leukoencephalopathy is not always reversible, and patients may develop epilepsy. Bone Marrow Transplantation (2000) 25, 331–334.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  1. Freise CE, Rowley H, Lake J et al. Similar clinical presentation of neurotoxicity following FK506 and cyclosporine in a liver transplant recipient Transplant Proc 1991 23: 3173–3174

    CAS  PubMed  Google Scholar 

  2. Small SL, Fukui MB, Bramblett GT, Eidelman BH . Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506) Ann Neurol 1996 40: 575–580

    Article  CAS  Google Scholar 

  3. Thyagarajan GK, Cobanoglu A, Johnston W . FK506-induced fulminant leukoencephalopathy after single-lung transplantation Ann Thorac Surg 1997 64: 1461–1464

    Article  CAS  Google Scholar 

  4. Shutter LA, Green JP, Newman NJ et al. Cortical blindness and white matter lesions in a patient receiving FK506 after liver transplantation Neurology 1993 43: 2417–2418

    Article  CAS  Google Scholar 

  5. Pizzolato GP, Sztajzel R, Burkhardt K et al. Cerebral vasculitis during FK506 treatment in liver transplant patient Neurology 1998 50: 1154–1157

    Article  CAS  Google Scholar 

  6. Hinchey J, Chaves C, Appignani B et al. A reversible posterior leukoencephalopathy syndrome New Engl J Med 1996 334: 494–500

    Article  CAS  Google Scholar 

  7. Steg RE, Kessinger A, Wszolek ZK . Cortical blindness and seizures in a patient receiving FK506 after bone marrow transplantation Bone Marrow Transplant 1999 23: 959–962

    Article  CAS  Google Scholar 

  8. Pettitt AR, Clark RE . Thrombotic microangiopathy following bone marrow transplantation Bone Marrow Transplant 1994 14: 495–504

    CAS  PubMed  Google Scholar 

  9. Iwasaki Y, Sako K, Ohara Y et al. Subacute panencephalitis associated with chronic graft-versus-host disease Acta Neuropathol 1993 85: 566–572

    CAS  PubMed  Google Scholar 

  10. Sharkey J, Butcher SP . Immunophilins mediate the neuroprotective effect of FK506 in focal cerebral ischaemia Nature 1994 371: 336–339

    Article  CAS  Google Scholar 

  11. Steiner JP, Dawson TM, Fotuhi M et al. High brain densities of the immunophilin FKBP colocalized with calcineurin Nature 1992 358: 584–587

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Misawa, A., Takeuchi, Y., Hibi, S. et al. FK506-induced intractable leukoencephalopathy following allogeneic bone marrow transplantation. Bone Marrow Transplant 25, 331–334 (2000). https://doi.org/10.1038/sj.bmt.1702143

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702143

Keywords

This article is cited by

Search

Quick links